Home・Lista de Ações・Compugen Ltd

Compugen Ltd

Abrir

2.04 -3.32

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

2.04

Máximo

2.1

Indicadores-chave
By Trading Economics
Rendimento	663K -7M
Vendas	426K 2.6M
P/E Médio do Setor	6.079 47.946
EPS	-0.07
Margem de lucro	-269.254
Funcionários	75
EBITDA	665K -7M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+117.39% upside

Dividendos
By Acuity
Próximos Ganhos	9 de nov. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-6.3M 219M
Abertura anterior	5.36
Fecho anterior	2.04

Compugen Ltd Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

12 de out. de 2026, 23:56 UTC

Owens Corning's shares advanced modestly in after-market trading, recovering from a session low earlier in the day while remaining below its 20-day moving average.

12 de out. de 2026, 23:56 UTC

Newell Brands Inc shares advanced modestly in after-market trading, fluctuating between negative and positive territory before retracing slightly from a peak.

12 de out. de 2026, 23:56 UTC

Social Media

Intercontinental Exchange Inc shares are trading lower in after-market hours, retracing from a peak shortly after the regular session ended.

12 de out. de 2026, 23:56 UTC

Roivant Sciences Ltd is trading higher in after-hours action, having previously peaked before a slight retracement, but remains below its 20-day moving average.

12 de out. de 2026, 23:56 UTC

Apollo Global Management Inc is trading higher in after-market hours, with cumulative returns fluctuating between a small loss and a modest gain.

12 de out. de 2026, 23:56 UTC

Ameriprise Financial Inc. is trading modestly lower in after-hours activity, retracing from a brief peak and remaining below its 20-day moving average.

12 de out. de 2026, 23:56 UTC

West Pharmaceutical Services Inc's shares advanced modestly during after-market hours, with a cumulative return peaking at 0.64% before settling around 0.36%.

12 de out. de 2026, 23:56 UTC

AAON shares declined modestly in after-market trading, shifting to a cumulative loss shortly after the session began.

12 de out. de 2026, 23:56 UTC

Social Media

News

Kroger Co. plans to cut about 3k corporate positions, or 37% of its workforce, as part of a restructuring initiative to improve efficiency.

12 de out. de 2026, 23:56 UTC

Stryker Corp's shares are roughly flat in after-market trading, fluctuating between a small loss and a marginal gain, remaining above the 20-day moving average.

12 de out. de 2026, 23:56 UTC

NextDecade Corp's shares advanced modestly during after-market hours, peaking at a 0.60% return before slightly retracing, reflecting routine performance.

12 de out. de 2026, 23:56 UTC

Bath & Body Works Inc shares are trading modestly lower in after-market hours, continuing a trend of declines observed over the last four sessions.

12 de out. de 2026, 23:56 UTC

Macro News

The US Dollar Index is trading roughly flat as investors await key inflation data on October 14, amid signals of potential further Fed tightening.

12 de out. de 2026, 23:56 UTC

Hess Midstream LP is trading modestly higher in after-market hours following a slight decline earlier in the session.

12 de out. de 2026, 23:56 UTC

eHealth Inc is seeing a notable increase in after-market trading, gaining ground since Monday's close.

12 de out. de 2026, 23:52 UTC

News

MYR Group Inc shares are trading lower in after-market hours, continuing a downward trend since Monday's close, despite an upcoming conference on November 11, 2026.

12 de out. de 2026, 23:51 UTC

Gray Media Inc shares are trading higher in after-market hours, following a period near the lower end of its one-month range.

12 de out. de 2026, 23:51 UTC

Fidelity National Information Services Inc shares declined modestly in after-market trading, reversing an earlier gain amid unusual volatility and moving below its 20-day average.

12 de out. de 2026, 23:51 UTC

Asana Inc shares are declining in after-market trading.

12 de out. de 2026, 23:51 UTC

Correlated Moves

Evergy Inc shares are modestly higher in after-market trading, influenced by a slight rise in Exelon Corp, which has shown unusual price movement.

12 de out. de 2026, 23:51 UTC

Patria Investments Ltd is trading lower in after-market hours, having declined from a brief peak shortly after the market closed and reaching its session low.

12 de out. de 2026, 23:51 UTC

Acacia Research Corp is trading lower in after-market hours, continuing a downward trend and currently about 2.27% below its 20-day moving average.

12 de out. de 2026, 23:51 UTC

Mesa Laboratories Inc shares declined in after-market trading, falling steadily to a level significantly below its 20-day moving average.

12 de out. de 2026, 23:51 UTC

American Electric Power Company Inc shares are trading modestly higher during after-market hours, breaking a recent trend of upward momentum in prior sessions.

12 de out. de 2026, 23:51 UTC

ZIM Integrated Shipping Services Ltd shares traded modestly lower in after-market hours, reversing a brief positive turn earlier in the session.

12 de out. de 2026, 23:51 UTC

Correlated Moves

Corning Inc shares are trading lower in after-market hours, diverging from recent higher daily closes amid ongoing geopolitical tensions and declines in South Korean stocks.

12 de out. de 2026, 23:51 UTC

Hewlett Packard Enterprise Co is declining in after-market trading, marking its lowest point of the day despite a strong one-month performance.

12 de out. de 2026, 23:51 UTC

American Financial Group Inc has advanced in after-market trading, significantly above its 20-day moving average and near the upper end of its one-month range.

12 de out. de 2026, 23:51 UTC

Market Cautiously Awaits U.S. Initial Jobless Claims Data Amid Economic Concerns and Inflation Indicators on October 15, 2026

12 de out. de 2026, 23:51 UTC

September 2026 Existing Home Sales Data Release Anticipates Continued Slump Amid Rising Mortgage Rates and Economic Uncertainty.

Comparação entre Pares

Variação de preço

Compugen Ltd Previsão

Preço-alvo

By TipRanks

117.39% parte superior

Previsão para 12 meses

Média 4.5 USD 117.39%

Máximo 6 USD

Mínimo 4 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Compugen Ltd - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

Comprar

Manter

Vender

Com base em 4 analistas que deram avaliações de ações para Compugen Ltd - Dist nos últimos 3 meses.

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.